AMN Healthcare Q2 revenue falls 25% to $741 million; GAAP EPS $0.42 vs. $1.55
AMN Healthcare reported second-quarter 2024 revenue of $741 million, down 25% from a year earlier, with GAAP diluted EPS of $0.42 compared with $1.55 in the second quarter of 2023. Its third-quarter outlook projects revenue of $660 million to $680 million, 20% to 23% below the prior year, which signals that the year-over-year decline is expected to continue.
Key points
- Q2 2024 revenue was $741 million, down 25% year over year and 10% from the first quarter.
- GAAP diluted EPS was $0.42 versus $1.55 a year earlier; adjusted diluted EPS was $0.98 versus $2.38.
- Third-quarter 2024 revenue guidance is $660 million to $680 million, 20% to 23% lower than the prior year.
- Operating cash flow was $100 million in the quarter, and the company reduced debt by $80 million; total debt was $1.195 billion at June 30, 2024.
The filing
Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 08, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.